Transform Wealth LLC Has $1.32 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Transform Wealth LLC decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 74.6% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,512 shares of the healthcare conglomerate's stock after selling 7,378 shares during the quarter. Transform Wealth LLC's holdings in UnitedHealth Group were worth $1,316,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also added to or reduced their stakes in the company. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth $26,000. Hurley Capital LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd bought a new stake in UnitedHealth Group in the 4th quarter worth about $30,000. Finally, Promus Capital LLC purchased a new stake in UnitedHealth Group during the 4th quarter valued at $32,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on UNH shares. Oppenheimer cut their price objective on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a report on Wednesday, May 14th. JPMorgan Chase & Co. dropped their price objective on UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating for the company in a report on Thursday, May 15th. Morgan Stanley dropped their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. Mizuho decreased their price objective on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a report on Friday, May 16th. Finally, Argus cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday, April 21st. One analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have given a buy rating to the company's stock. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and an average price target of $426.52.

UnitedHealth Group Trading Down 1.7%

NYSE UNH traded down $5.37 during trading hours on Friday, reaching $313.13. The company had a trading volume of 9,413,889 shares, compared to its average volume of 7,161,072. The stock has a market capitalization of $284.05 billion, a P/E ratio of 20.20, a price-to-earnings-growth ratio of 1.37 and a beta of 0.45. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The stock has a 50-day moving average of $391.47 and a 200 day moving average of $476.22.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period last year, the company earned $6.91 earnings per share. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be issued a dividend of $2.21 per share. The ex-dividend date is Monday, June 16th. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 2.82%. UnitedHealth Group's payout ratio is currently 37.02%.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn acquired 1,533 shares of the stock in a transaction that occurred on Wednesday, May 14th. The shares were purchased at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the transaction, the director now owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO John F. Rex purchased 17,175 shares of the business's stock in a transaction dated Friday, May 16th. The shares were acquired at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the acquisition, the chief financial officer now directly owns 203,796 shares in the company, valued at $59,329,091.52. This represents a 9.20% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders purchased 109,408 shares of company stock worth $31,607,768. Insiders own 0.28% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.